Shortly after acquiring Elektrofi to beef up its subcutaneous drug-delivery offerings, Halozyme Therapeutics has struck ...

Biopharmaceuticals (biologics) are complex drugs made from living sources, not chemical processes. The government is planning ...

The MarketWatch News Department was not involved in the creation of this content. HANGZHOU, China and SHANGHAI and BOSTON, Dec. 10, 2025 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter ...

DORADO, PR / ACCESS Newswire / January 29, 2026 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV), a regulatory affairs, quality, compliance, project management and technology ...

The Union Budget 2026–27 proposed a Rs 10,000 crore Bio Pharma Shakti scheme to boost biologics and biosimilars, alongside ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Best Cheap Stocks to Buy Right Now. Barclays initiated coverage of ...

Finance Minister Nirmala Sitharaman on Sunday announced a Rs 10,000 crore outlay for the Bio Pharma Shakti scheme for ...

China quietly became biotech’s back-office, from molecule synthesis and clinical trials to novel drug licensing. Now the industry—and Washington—are rethinking the risks.

Non-communicable diseases, geriatric care and manufacturing of bio-pharmaceuticals received a mention in Budget 2026, aside ...

Processa Pharmaceuticals, Inc. announced its participation in the 2025 BIO International Convention from June 16-19 in Boston, where key executives, including CEO Georg Ng and President of R&D Dr.

Why BridgeBio Pharma (BBIO) is on investors’ radar BridgeBio Pharma (BBIO) has drawn fresh attention after recent share price moves, with the stock showing mixed short term performance and stronger ...